VICTORIA, Nov. 1 /PRNewswire-FirstCall/ - Aspreva Pharmaceuticals Corporation today announced that Bruce Cousins, Aspreva’s Chief Financial Officer, will present at the Rodman & Renshaw 7th Annual Techvest Healthcare Conference in New York.
The 20-minute presentation followed by a 20-minute break-out session will take place on Tuesday, November 8th at 10:50 am ET at the New York Palace Hotel.
A live audio webcast of Mr. Cousins’ presentation will be available to all interested parties through a link posted on Aspreva’s website at www.aspreva.com in the Investors section.
About Aspreva Pharmaceuticals
Aspreva is an emerging pharmaceutical company focused on identifying, developing and upon regulatory approval, commercializing new indications for approved drugs and late stage drug candidates for less common diseases. Aspreva’s “Indication Partnering” strategy allows its partners to maintain core brand focus while extending the benefits of their medicines to a broader patient population. Aspreva is listed on the Nasdaq National Market under the trading symbol “ASPV” and on the Toronto Stock Exchange under the trading symbol “ASV”.
For further information please contact: Sage Baker Director, Corporate Communications Aspreva Pharmaceuticals 250-744-2488 ext. 270 sbaker@aspreva.com
Aspreva Pharmaceuticals
CONTACT: Sage Baker, Director, Corporate Communications, AsprevaPharmaceuticals, (250) 744-2488 ext. 270, sbaker@aspreva.com
